Related Experiment Video
Updated: Jul 9, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Preventing evolutionary rescue in cancer
Srishti Patil1,2, Armaan Ahmed3,4, Yannick Viossat5
1Indian Institute of Science Education and Research, Pune, India.
Abstract:
First-line cancer treatment frequently fails due to initially rare therapeutic resistance. An important clinical question is then how to schedule subsequent treatments to maximize the probability of tumour eradication. Here, we provide a theoretical solution to this problem by using mathematical analysis and extensive stochastic simulations within the framework of evolutionary rescue theory to determine how best to exploit the vulnerability of small tumours to stochastic extinction. Whereas standard clinical practice is to wait for evidence of relapse, we confirm a recent hypothesis that the optimal time to switch to a second treatment is when the tumour is close to its minimum size before relapse, when it is likely undetectable. This optimum can lie slightly before or slightly after the nadir, depending on tumour parameters. Given that this exact time point may be difficult to determine in practice, we study windows of high extinction probability that lie around the optimal switching point, showing that switching after the relapse has begun is typically better than switching too early. We further reveal how treatment dose and tumour demographic and evolutionary parameters influence the predicted clinical outcome, and we determine how best to schedule drugs of unequal efficacy. Our work establishes a foundation for further experimental and clinical investigation of this evolutionarily-informed "extinction therapy" strategy.
Insights
Optimizing cancer therapy involves switching treatments when tumors are smallest, ideally near their minimum size before relapse. This "extinction therapy" strategy, based on evolutionary rescue theory, aims to maximize tumor eradication probability.
Area of Science:
- Oncology
- Mathematical Biology
- Evolutionary Biology
Background:
- First-line cancer treatments often fail due to emerging therapeutic resistance in rare cancer cells.
- Clinical challenge lies in optimizing the scheduling of subsequent treatments to achieve complete tumor eradication.
- Understanding tumor dynamics and evolutionary principles is crucial for developing effective treatment strategies.
Purpose of the Study:
- To provide a theoretical framework for scheduling sequential cancer treatments to maximize tumor eradication.
- To identify the optimal timing for switching treatments based on tumor size and evolutionary dynamics.
- To explore the influence of treatment parameters and tumor characteristics on clinical outcomes.
Main Methods:
- Utilized mathematical analysis and extensive stochastic simulations.
- Applied the framework of evolutionary rescue theory to model tumor extinction.
- Investigated the impact of treatment timing, dose, and tumor parameters on eradication probability.
Main Results:
- Confirmed that the optimal time to switch treatment is near the tumor's minimum size (nadir) before relapse.
- Identified windows of high extinction probability around the optimal switching point, suggesting later switching is often preferable to switching too early.
- Demonstrated that treatment dose, tumor demographics, and evolutionary parameters significantly influence outcomes, and provided guidance for scheduling drugs with unequal efficacy.
Conclusions:
- An evolutionarily-informed 'extinction therapy' strategy, focusing on exploiting tumor vulnerability at its smallest size, offers a theoretical basis for optimizing sequential cancer treatment.
- Switching treatments around the tumor nadir, with a preference for switching after relapse initiation if the exact nadir is uncertain, can enhance eradication probability.
- This study provides a foundation for experimental and clinical investigations into optimizing cancer treatment scheduling based on evolutionary principles.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Replicative Cell Senescence
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

